NASDAQ:AKTX - Akari Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$4.10 -0.40 (-8.89 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$4.50
Today's Range$3.90 - $4.50
52-Week Range$1.56 - $9.20
Volume879,157 shs
Average Volume2.22 million shs
Market Capitalization$62.55 million
P/E Ratio-14.64
Dividend YieldN/A
Beta-3.96

Analyst Ratings

Akari Therapeutics (NASDAQ:AKTX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Akari Therapeutics in the last 12 months. Their average twelve-month price target is $7.50, suggesting that the stock has a possible upside of 82.93%. The high price target for AKTX is $8.00 and the low price target for AKTX is $7.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.502.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.50$5.50$5.50$5.50
Price Target Upside: 82.93% upside225.44% upside202.20% upside202.20% upside

Akari Therapeutics (NASDAQ:AKTX) Consensus Price Target History

Price Target History for Akari Therapeutics (NASDAQ:AKTX)

Akari Therapeutics (NASDAQ:AKTX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/19/2019B. RileySet Price TargetBuy$7.00LowView Rating Details
3/29/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$15.00 ➝ $8.00LowView Rating Details
9/22/2017William BlairUpgradeMarket Perform ➝ OutperformHighView Rating Details
9/17/2017Chardan CapitalReiterated RatingNeutralLowView Rating Details
(Data available from 3/20/2017 forward)
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel